JP2005255529A - Skin care preparation for external use - Google Patents

Skin care preparation for external use Download PDF

Info

Publication number
JP2005255529A
JP2005255529A JP2004065084A JP2004065084A JP2005255529A JP 2005255529 A JP2005255529 A JP 2005255529A JP 2004065084 A JP2004065084 A JP 2004065084A JP 2004065084 A JP2004065084 A JP 2004065084A JP 2005255529 A JP2005255529 A JP 2005255529A
Authority
JP
Japan
Prior art keywords
extract
skin
effect
skin care
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004065084A
Other languages
Japanese (ja)
Other versions
JP4541728B2 (en
Inventor
Misako Kobayashi
三佐子 小林
Keisuke Nakano
恵介 中野
Hisami Arakane
久美 荒金
Hiroaki Shindo
宏昭 神藤
Kosuke Nosaka
浩資 野坂
Hiroyasu Ishii
浩康 石井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kose Corp
Hiro International Co Ltd
Original Assignee
Kose Corp
Hiro International Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kose Corp, Hiro International Co Ltd filed Critical Kose Corp
Priority to JP2004065084A priority Critical patent/JP4541728B2/en
Publication of JP2005255529A publication Critical patent/JP2005255529A/en
Application granted granted Critical
Publication of JP4541728B2 publication Critical patent/JP4541728B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

<P>PROBLEM TO BE SOLVED: To provide a skin care preparation for external use excellent in bleaching and/or antiaging effect. <P>SOLUTION: This skin care preparation for external use comprises an extract of Tithonia diversifolia (Hemsl) A. Gray as an active ingredient, particularly as a bleaching agent or an antioxidant. The skin care preparation for external use can be supplied to various kinds of applications, e.g. cosmetics, quasi-drugs and external medicines. Since the skin care preparation for external use is excellent in bleaching effect and/or antiaging effect, the preparation is particularly useful as a cosmetic. <P>COPYRIGHT: (C)2005,JPO&NCIPI

Description

本発明は、キク科ニトベギクの抽出物を利用した皮膚外用剤に関する。   The present invention relates to an external preparation for skin using an extract of Asteraceae Nitobegiku.

従来、皮膚外用剤には、有効成分として、植物の抽出物等、種々の天然物由来の成分が利用されている。例えば、ヨクイニン抽出物、又はキク科カミツレ抽出物は、美白効果があることが知られ、該抽出物を含有する化粧料が提案されている。しかし、従来の薬効剤ではその効果が不充分であり、より優れた美白効果等を奏する、新たな天然物由来の薬効剤が求められている。   Conventionally, in skin external preparations, various natural product-derived components such as plant extracts have been used as active ingredients. For example, Yokuinin extract or Asteraceae chamomile extract is known to have a whitening effect, and cosmetics containing the extract have been proposed. However, the effects of conventional medicinal agents are insufficient, and a new natural product-derived medicinal agent that exhibits a more excellent whitening effect or the like is demanded.

本発明は、肌に適用した際の薬効、特に美白効果及び/又は老化防止効果に優れ、安定性も良好な皮膚外用剤を提供することを課題とする。   This invention makes it a subject to provide the skin external preparation which is excellent in the medicinal effect at the time of applying to skin, especially the whitening effect and / or the anti-aging effect, and favorable stability.

本発明は、ニトベギク抽出物を有効成分として含む皮膚外用剤を提供する。本発明では、前記ニトベギク抽出物は、美白剤として及び/又は老化防止剤として皮膚外用剤に含有される。
また、別の観点から、本発明によって、ニトベギク抽出物からなるメラニン生成抑制剤;ニトベギク抽出物からなる活性酸素トラップ剤;ニトベギク抽出物を適用することを含むメラニン生成抑制方法;ニトベギク抽出物を適用することを含む活性酸素の消去方法;ニトベギク抽出物を適用することを含む肌の美白方法;ニトベギク抽出物を適用することを含む肌の老化防止方法;及びニトベギク抽出物を添加することを含む皮膚外用剤の製造方法;が提供される。
The present invention provides an external preparation for skin containing nitobegiku extract as an active ingredient. In the present invention, the nitobegiku extract is contained in a skin external preparation as a whitening agent and / or as an anti-aging agent.
From another point of view, according to the present invention, a melanin production inhibitor composed of a nitrite extract; a reactive oxygen trap comprising a nitrite extract; a melanin production inhibition method comprising applying a nitrite extract; A method for eliminating active oxygen comprising: applying a nitrite extract; a method for whitening the skin; applying a nitrite extract; and a skin comprising adding a nitrite extract. A method for producing an external preparation is provided.

本発明によれば、種々の薬効、特に美白効果及び/又は老化防止効果に優れた、安定性の良好な皮膚外用剤を提供することができる。   ADVANTAGE OF THE INVENTION According to this invention, the skin external preparation with favorable stability excellent in various medicinal effects, especially the whitening effect and / or anti-aging effect can be provided.

以下、本発明について詳細に説明する。
本発明の皮膚外用剤は、キク科ニトベギク(学名: Tithonia diversifolia (Hemsl) A. Gray)の抽出物を有効成分として含有する。ニトベギクの葉、茎、根、花等種々の部分の抽出物を利用することができるが、葉の抽出物を用いるのが好ましい。又、本発明には、前記ニトベギクの2箇所以上の部分から得られた抽出物を混合して用いてもよく、あるいは2箇所以上の部分から異なる溶媒により抽出された抽出物を二種以上混合して用いてもよい。
Hereinafter, the present invention will be described in detail.
The external preparation for skin of the present invention contains an extract of the asteraceae Nitobegiku (scientific name: Tithonia diversifolia (Hemsl) A. Gray) as an active ingredient. Extracts of various parts such as leaves, stems, roots, flowers, etc. can be used, but it is preferable to use leaf extracts. In the present invention, extracts obtained from two or more parts of the nitrite may be mixed and used, or two or more extracts extracted from two or more parts with different solvents may be mixed. May be used.

ニトベギク抽出物の調製方法については特に制限されず、一般的な抽出方法を利用して調製することができる。例えば、ニトベギクの葉を、50〜100℃の溶媒中に所定の時間浸漬することによって調製することができる。抽出溶媒としては特に限定されないが、例えば、水;メチルアルコール、エチルアルコール等の低級一価アルコール;グリセリン、プロピレングリコール、1,3−ブチレングリコール等の液状多価アルコール;アセトン等のケトン類;エチルエーテル等のエーテル類;酢酸エチル等のエステル類;等の1種又は2種以上を用いることができる。中でも水が好ましく、熱水(50〜100℃)中に浸漬して抽出するのが好ましい。また、抽出溶媒は、ニトベギクの葉等に対して質量で2〜8倍程度用いるのが好ましい。抽出時間は、溶媒の種類又は抽出温度等によって好ましい範囲も異なるが、一般的には60〜100分が好ましい。   The method for preparing the nitobegiku extract is not particularly limited, and can be prepared using a general extraction method. For example, it can be prepared by immersing Nitobegi leaves in a solvent at 50 to 100 ° C. for a predetermined time. Although it does not specifically limit as an extraction solvent, For example, Water; Lower monohydric alcohols, such as methyl alcohol and ethyl alcohol; Liquid polyhydric alcohols, such as glycerol, propylene glycol, and 1, 3- butylene glycol; Ketones, such as acetone; Ethyl One or more of ethers such as ether; esters such as ethyl acetate; and the like can be used. Among these, water is preferable, and it is preferable to extract by dipping in hot water (50 to 100 ° C.). Moreover, it is preferable to use about 2-8 times as much mass as an extraction solvent with respect to the leaf etc. of a nitrite. Although the preferable range of the extraction time varies depending on the type of solvent or the extraction temperature, it is generally preferably 60 to 100 minutes.

前記ニトベギク抽出物は、そのまま皮膚外用剤に配合してもよいし、適宜の期間そのまま放置し熟成させた後に用いることもできる。必要ならば、本発明の効果に影響のない範囲で、更に、濾過又はイオン交換樹脂等により、脱臭、脱色等の精製処理を施して用いることもできる。又、液体クロマトグラフィー等の分離手段を用い、活性の高い画分を取り出して用いることもできる。   The nitobegiku extract may be used as it is in a skin external preparation, or may be used after being left to mature for an appropriate period. If necessary, it can be used after being subjected to a purification treatment such as deodorization and decolorization by filtration or ion exchange resin within a range that does not affect the effect of the present invention. Further, a fraction having high activity can be taken out and used by using a separation means such as liquid chromatography.

前記ニトベギクの抽出物は、液状、ペースト状、ゲル状等いずれの形態であってもよい。抽出溶媒を含む液状の抽出物を、減圧乾燥、又は凍結乾燥などにより乾固させて固体状とした後に用いることもできる。また、スプレードライ等により乾燥させて粉末として用いることもできる。   The extract of nitobegiku may be in any form such as liquid, paste or gel. The liquid extract containing the extraction solvent can also be used after it is solidified by drying under reduced pressure or freeze drying. It can also be dried by spray drying or the like and used as a powder.

本発明の皮膚外用剤は、有効成分である前記ニトベギク抽出物によって奏される、優れた美白効果及び/又は老化防止効果を奏する。なお、本明細書において、「老化防止」とは、生体細胞組織に対する老化防止作用のことを意味するものとする。特に、皮膚用の「老化防止」とは、加齢、紫外線曝露等により生じる皮膚(頭皮、唇、粘膜を含む)のしわやたるみ、張りや弾力性の低下に加え、皮膚の保水能の減少等の皮膚の老化を予防あるいは改善する等の老化防止作用を意味するものとする。これらの作用を示す限り、老化防止作用を発現するメカニズムについては特に制限されない。例えば、「抗酸化効果」及び「細胞賦活効果」により発現する効果も「老化防止」の範囲に含まれる。また、本明細書において「美白」の用語は、肌を白くする積極的効果のみならず、肌の黒化を抑制する消極的効果も含む意味で用いるものとする。例えば、しみ、そばかす等の色素沈着を改善する効果のみならず、色素沈着を抑制する効果も含むものとする。   The skin external preparation of this invention has the outstanding whitening effect and / or antiaging effect which are show | played by the said nitobegiku extract which is an active ingredient. In the present specification, “anti-aging” means an anti-aging action on living cell tissues. In particular, “anti-aging” for skin means wrinkles and sagging of skin (including scalp, lips and mucous membranes) caused by aging, UV exposure, etc., reduced tension and elasticity, and reduced water retention capacity of skin It means an anti-aging action such as prevention or improvement of skin aging such as. As long as these actions are exhibited, there is no particular limitation on the mechanism that exhibits the anti-aging action. For example, the effects exhibited by “antioxidant effect” and “cell activation effect” are also included in the range of “anti-aging”. Further, in the present specification, the term “whitening” is used to include not only the positive effect of whitening the skin but also the negative effect of suppressing the blackening of the skin. For example, it includes not only the effect of improving pigmentation such as spots and freckles but also the effect of suppressing pigmentation.

本発明の皮膚外用剤における前記ニトベギク抽出物(乾燥固形物)の含有量は、好ましくは0.00001〜5質量%(以下単に「%」で示す)であり、より好ましくは0.0001〜2%である。この範囲内であれば、前記ニトベギク抽出物を安定に配合することができ、かつ高い美白効果又は老化防止効果を発揮することができる。又、溶液として抽出物を使用する場合は、溶質である乾燥固形分の含有量が上記範囲内であれば、その抽出液濃度は何ら限定されるものではない。   The content of the nitobegiku extract (dry solid) in the external preparation for skin of the present invention is preferably 0.00001 to 5% by mass (hereinafter simply referred to as “%”), more preferably 0.0001 to 2%. %. If it is in this range, the above-mentioned nitrite extract can be blended stably, and a high whitening effect or anti-aging effect can be exhibited. When the extract is used as a solution, the concentration of the extract is not limited as long as the content of the dry solid content as a solute is within the above range.

本発明の皮膚外用剤には、本発明の効果を損なわない範囲で、通常、化粧料や医薬部外品、外用医薬品等の製剤に使用される成分、水(精製水、温泉水、深層水等)、油剤、界面活性剤、金属セッケン、ゲル化剤、粉体、アルコール類、水溶性高分子、皮膜形成剤、樹脂、包接化合物、抗菌剤、香料、消臭剤、塩類、pH調整剤、清涼剤、植物・動物・微生物由来の抽出物、活性酸素除去剤、血行促進剤、収斂剤、抗脂漏剤、保湿剤、キレート剤、角質溶解剤、酵素、ホルモン類、ビタミン類等を必要に応じて加えることができる。   In the external preparation for skin of the present invention, as long as the effects of the present invention are not impaired, components, water (purified water, hot spring water, deep layer water) that are usually used in preparations such as cosmetics, quasi drugs, and external medicines are used. Etc.), oil agent, surfactant, metal soap, gelling agent, powder, alcohol, water-soluble polymer, film-forming agent, resin, inclusion compound, antibacterial agent, fragrance, deodorant, salt, pH adjustment Agents, fresheners, extracts from plants, animals and microorganisms, active oxygen scavengers, blood circulation promoters, astringents, antiseborrheic agents, moisturizers, chelating agents, keratolytic agents, enzymes, hormones, vitamins, etc. Can be added as needed.

アルコールは、溶解、清涼感、防腐、保湿等の目的で用いられる。本発明に使用可能なアルコールの例には、エタノール等の低級アルコール;及びグリセリン、ジグリセリン、エチレングリコール、ジエチレングリコール、プロピレングリコール、ジプロピレングリコ−ル、1,3-ブチレングリコール、ポリエチレングリコール等の多価アルコール;等が含まれる。   Alcohol is used for the purpose of dissolution, refreshing feeling, antiseptic, moisturizing and the like. Examples of alcohols that can be used in the present invention include lower alcohols such as ethanol; and various alcohols such as glycerin, diglycerin, ethylene glycol, diethylene glycol, propylene glycol, dipropylene glycol, 1,3-butylene glycol, and polyethylene glycol. And the like.

油剤は、基剤の構成成分としては、又は使用性もしくは使用感を改善する目的で用いられる。通常の化粧料に使用されるものであればいずれも使用することができ、天然系油であるか、合成油であるか等の由来について、又は、固体、半固体、液体であるか等の性状については問わない。本発明には、炭化水素類、ロウ類、脂肪酸類、高級アルコール類、エステル油、シリコーン油類、フッ素系油類等を使用することができる。より具体的には、流動パラフィン、スクワラン、ワセリン等の炭化水素類、トリ2−エチルヘキサン酸セチル、テトラ2−エチルヘキサン酸ペンタエリスリット等の合成エステル油、オリーブ油、ヒマシ油、ホホバ油、ミンク油、マカデミアンナッツ油、杏仁油、パーシック油、サフラワー油、ヒマワリ油、アボガド油、メドゥホーム油、ツバキ油、アーモンド油、エゴマ油、ゴマ油、ボラージ油、シア脂等の植物や動物由来の油脂、ミツロウ、カルナウバロウ、キャンデリラロウ、ゲイロウ等のロウ類等を用いることができる。   The oil is used as a component of the base or for the purpose of improving usability or feeling of use. Any of those used in normal cosmetics can be used, such as whether it is a natural oil or a synthetic oil, or whether it is a solid, semi-solid, liquid, etc. It doesn't matter about the properties. In the present invention, hydrocarbons, waxes, fatty acids, higher alcohols, ester oils, silicone oils, fluorine oils and the like can be used. More specifically, hydrocarbons such as liquid paraffin, squalane and petrolatum, synthetic ester oils such as cetyl tri-2-ethylhexanoate and pentaerythritol tetra-2-ethylhexanoate, olive oil, castor oil, jojoba oil, mink Oil, macadamia nut oil, apricot oil, persic oil, safflower oil, sunflower oil, avocado oil, medhome oil, camellia oil, almond oil, egoma oil, sesame oil, borage oil, shea butter, etc. Oils, beeswax, carnauba wax, candelilla wax, gaywax and other waxes can be used.

使用可能な紫外線防御剤の例には、パラメトキシケイ皮酸−2−エチルヘキシル、2−ヒドロキシ−4−メトキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン−5−硫酸ナトリウム、4−ブチル−4‘−メトキシジベンゾイルメタン、2−フェニル−ベンズイミダゾール−5−硫酸、酸化チタン、酸化亜鉛等が挙げられる。   Examples of UV protection agents that can be used include para-methoxycinnamate-2-ethylhexyl, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxybenzophenone-5 sodium sulfate, 4-butyl-4 ′ -Methoxydibenzoylmethane, 2-phenyl-benzimidazole-5-sulfuric acid, titanium oxide, zinc oxide and the like.

水溶性高分子は、系の安定化のため、又は使用性もしくは使用感を改良するために用いられ、又保湿効果を得るためにも用いられる。使用可能な水溶性高分子の例には、カラギーナン、ペクチン、寒天、ローカストビーンガム等の植物系高分子、キサンタンガム等の微生物系高分子、ゼラチン等の動物系高分子、デンプン等のデンプン系高分子、メチルセルロース、カルボキシメチルセルロース、ヒドロキシプロピルセルロース等のセルロース系高分子、アルギン酸ナトリウム等のアルギン酸系高分子、カルボキシビニルポリマー等のビニル系高分子等が含まれる。   The water-soluble polymer is used for stabilizing the system, improving usability or feeling of use, and also for obtaining a moisturizing effect. Examples of water-soluble polymers that can be used include plant polymers such as carrageenan, pectin, agar, locust bean gum, microbial polymers such as xanthan gum, animal polymers such as gelatin, and starch-based polymers such as starch. Examples include molecules, cellulosic polymers such as methylcellulose, carboxymethylcellulose, and hydroxypropylcellulose, alginic acid polymers such as sodium alginate, vinyl polymers such as carboxyvinyl polymer, and the like.

防腐剤、抗菌剤としては、安息香酸、安息香酸ナトリウム、パラオキシ安息香酸エステル、塩化ベンザルコニウム、フェノキシエタノール、イソプロピルメチルフェノール等が挙げられる。   Examples of antiseptics and antibacterial agents include benzoic acid, sodium benzoate, paraoxybenzoic acid ester, benzalkonium chloride, phenoxyethanol, isopropylmethylphenol, and the like.

ニトベギク抽出物は単独で優れた美白効果を有するが、本発明の効果をさらに向上させるために、従来公知の美白剤を併用してもよい。美白剤は日焼け等により生じる皮膚の黒化、色素沈着により生ずるシミ、ソバカス等の現象を防止する目的で用いられる。使用可能な他の美白剤の例には、アルブチン、エラグ酸、リノール酸、ビタミンC及びその誘導体、ビタミンE及びその誘導体、グリチルリチン酸及びその誘導体、トラネキサム酸、胎盤抽出物、カミツレ抽出物、カンゾウ抽出物、エイジツ抽出物、オウゴン抽出物、海藻抽出物、クジン抽出物、ケイケットウ抽出物、ゴカヒ抽出物、コメヌカ抽出物、小麦胚芽抽出物、サイシン抽出物、サンザシ抽出物、サンペンズ抽出物、シラユリ抽出物、シャクヤク抽出物、センプクカ抽出物、大豆抽出物、茶抽出物、糖蜜抽出物、ビャクレン抽出物、ブドウ抽出物、ホップ抽出物、マイカイカ抽出物、モッカ抽出物、ユキノシタ抽出物、ヨクイニン抽出物等が含まれる。   Nitobegiku extract alone has an excellent whitening effect, but in order to further improve the effect of the present invention, a conventionally known whitening agent may be used in combination. The whitening agent is used for the purpose of preventing skin blackening caused by sunburn and the like, spots such as spots and freckles caused by pigmentation. Examples of other whitening agents that can be used include arbutin, ellagic acid, linoleic acid, vitamin C and its derivatives, vitamin E and its derivatives, glycyrrhizic acid and its derivatives, tranexamic acid, placenta extract, chamomile extract, licorice Extract, Ages extract, Ogon extract, Seaweed extract, Kujin extract, Caiket extract, Gokahi extract, Rice bran extract, Wheat germ extract, Saisin extract, Hawthorn extract, Sunpens extract, Shirayuri extract , Peonies extract, Sempukuka extract, soybean extract, tea extract, molasses extract, sandalwood extract, grape extract, hop extract, micaika extract, mokka extract, yukinoshita extract, Yokuinin extract, etc. Is included.

抗炎症剤は、日焼け後の皮膚のほてりや紅斑等の炎症を抑制する目的で用いられる。本発明に使用可能な抗炎症剤の例には、イオウ及びその誘導体、グリチルリチン酸及びその誘導体、グリチルレチン酸及びその誘導体、アロエ抽出物、アルテア抽出物、アシタバ抽出物、アルニカ抽出物、インチンコウ抽出物、イラクサ抽出物、オウバク抽出物、オトギリソウ抽出物、カミツレ抽出物、キンギンカ抽出物、クレソン抽出物、コンフリー抽出物、サルビア抽出物、シコン抽出物、シソ抽出物、シラカバ抽出物、ゲンチアナ抽出物等が含まれる。   Anti-inflammatory agents are used for the purpose of suppressing inflammation such as hot flashes and erythema after sunburn. Examples of anti-inflammatory agents that can be used in the present invention include sulfur and its derivatives, glycyrrhizic acid and its derivatives, glycyrrhetinic acid and its derivatives, aloe extract, artea extract, ashitaba extract, arnica extract, inchinkou extract , Nettle extract, duckweed extract, hypericum extract, chamomile extract, goldfish extract, watercress extract, comfrey extract, salvia extract, lion extract, perilla extract, birch extract, gentian extract, etc. Is included.

ニトベギク抽出物は単独で優れた細胞賦活効果を有するが、本発明の効果をさらに向上させるために、さらに従来公知の細胞賦活剤を併用してもよい。細胞賦活剤は、肌荒れの改善等の目的で用いられる。本発明に使用可能な細胞賦活剤の例には、カフェイン、鶏冠抽出物、貝殻抽出物、貝肉抽出物、ローヤルゼリー、シルクプロテイン及びその分解物又はそれらの誘導体、ラクトフェリン又はその分解物、コンドロイチン硫酸、ヒアルロン酸等のムコ多糖類またはそれらの塩、コラーゲン、酵母抽出物、乳酸菌抽出物、ビフィズス菌抽出物、醗酵代謝抽出物、イチョウ抽出物、オオムギ抽出物、センブリ抽出物、タイソウ抽出物、ニンジン抽出物、ローズマリー抽出物、グリコール酸、クエン酸、乳酸、リンゴ酸、酒石酸、コハク酸等の有機酸及びそれらの誘導体等が含まれる。   Nitobegi extract has an excellent cell activation effect by itself, but in order to further improve the effect of the present invention, a conventionally known cell activation agent may be used in combination. The cell activator is used for the purpose of improving rough skin. Examples of cell activators that can be used in the present invention include caffeine, chicken crown extract, shell extract, shell extract, royal jelly, silk protein and its degradation product or derivatives thereof, lactoferrin or its degradation product, chondroitin Mucopolysaccharides such as sulfuric acid and hyaluronic acid or salts thereof, collagen, yeast extract, lactic acid bacteria extract, bifidobacteria extract, fermentation metabolic extract, ginkgo biloba extract, barley extract, assembly extract, thymus extract, Examples include carrot extract, rosemary extract, organic acids such as glycolic acid, citric acid, lactic acid, malic acid, tartaric acid, succinic acid, and derivatives thereof.

ニトベギク抽出物は単独で優れた活性酸素消去能を有するが、本発明の効果をさらに向上させるために、さらに従来公知の活性酸素除去剤を併用してもよい。活性酸素除去剤は、過酸化脂質生成抑制等の酸化障害抑制の目的で用いられる。本発明に使用可能な活性酸素除去剤の例には、スーパーオキサイドディスムターゼ、マンニトール、クエルセチン、カテキン及びその誘導体、ルチン及びその誘導体、ボタンピ抽出物、ヤシャジツ抽出物、メリッサ抽出物、羅漢果抽出物、レチノール及びその誘導体、カロチノイド等のビタミンA類、チアミンおよびその誘導体、リボフラビンおよびその誘導体、ピリドキシンおよびその誘導体、ニコチン酸およびその誘導体等のビタミンB類、トコフェロール及びその誘導体等のビタミンE類、ジブチルヒドロキシトルエン及びブチルヒドロキシアニソール等が含まれる。   Nitobegiku extract alone has an excellent active oxygen scavenging ability, but in order to further improve the effects of the present invention, a conventionally known active oxygen remover may be used in combination. The active oxygen scavenger is used for the purpose of suppressing oxidative damage such as lipid peroxide production suppression. Examples of active oxygen scavengers that can be used in the present invention include superoxide dismutase, mannitol, quercetin, catechin and derivatives thereof, rutin and derivatives thereof, bopi extract, yashajitsu extract, melissa extract, rahan extract, retinol And derivatives thereof, vitamin A such as carotenoid, thiamine and derivative thereof, riboflavin and derivative thereof, pyridoxine and derivative thereof, vitamin B such as nicotinic acid and derivative thereof, vitamin E such as tocopherol and derivative thereof, dibutylhydroxytoluene And butylhydroxyanisole.

本発明に使用可能な保湿剤の例には、エラスチン、ケラチン等のタンパク質またはそれらの誘導体、加水分解物並びにそれらの塩、グリシン、セリン、アスパラギン酸、グルタミン酸、アルギニン、テアニン等のアミノ酸及びそれらの誘導体、ソルビトール、エリスリトール、トレハロース、イノシトール、グルコース、蔗糖およびその誘導体、デキストリン及びその誘導体、ハチミツ等の糖類、D−パンテノール及びその誘導体、尿素、リン脂質、セラミド、オウレン抽出物、ショウブ抽出物、ジオウ抽出物、センキュウ抽出物、ゼニアオイ抽出物、タチジャコウソウ抽出物、ドクダミ抽出物、ハマメリス抽出物、ボダイジュ抽出物、マロニエ抽出物、マルメロ抽出物等が含まれる。   Examples of humectants that can be used in the present invention include proteins such as elastin and keratin or derivatives thereof, hydrolysates and salts thereof, amino acids such as glycine, serine, aspartic acid, glutamic acid, arginine, and theanine, and their Derivatives, sorbitol, erythritol, trehalose, inositol, glucose, sucrose and derivatives thereof, dextrin and derivatives thereof, saccharides such as honey, D-pantenol and derivatives thereof, urea, phospholipid, ceramide, auren extract, shobu extract, Examples of the present invention include terrestrial extract, nematode extract, mallow extract, gypsophila extract, dokudami extract, hamamelis extract, bodaige extract, maronier extract, quince extract and the like.

本発明の皮膚外用剤の形態の例としては、特に限定されず、例えば、乳液、クリーム、化粧水、パック、美容液、洗浄料、メーキャップ化粧料、分散液、軟膏、液剤、エアゾール剤、貼布剤、パップ剤、リニメント剤等のいずれの形態の化粧料であっても外用医薬品等であってもよい。   Examples of the form of the external preparation for skin of the present invention are not particularly limited. For example, emulsions, creams, lotions, packs, cosmetics, cleansing agents, makeup cosmetics, dispersions, ointments, liquids, aerosols, patches It may be any form of cosmetic such as a cloth, a poultice, a liniment or the like, or an external medicine.

以下に実施例を挙げて本発明をさらに具体的に説明するが、本発明の範囲は下記の実施例に限定されることはない。   The present invention will be described more specifically with reference to the following examples. However, the scope of the present invention is not limited to the following examples.

[例1:ニトベギク抽出物の調製]
乾燥したニトベギク(Tithonia diversifolia (Hemsl) A. Gray)の全草500gに3リットルの水を入れ、熱水中で抽出し、減圧濃縮した後、凍結乾燥して70gの抽出物を得た。
[例2:比較用試料(カミツレ抽出物及びヨクイニン抽出物)の調製]
キク科カミルレ属カミツレ(Matricaria chamomilla L.)の花の混合物各10gに、1,3−ブチレングリコールを50mL加え、室温にて10日間、攪拌しながら抽出を行ない、濾過して、濾液(カミツレ抽出物)を得た。カミツレ抽出物の乾燥固形分は0.35%であった。
ヨクイニン(日局)10gに、70vol%含水エチルアルコール100mLを加え、室温にて3日間抽出を行った後、濾過してヨクイニン抽出物を得た。ヨクイニン抽出物の乾燥固形分は0.8%であった。
[Example 1: Preparation of nitobegiku extract]
3 liters of water was placed in 500 g of dried Nitobegiku (Tithonia diversifolia (Hemsl) A. Gray), extracted in hot water, concentrated under reduced pressure, and lyophilized to obtain 70 g of extract.
[Example 2: Preparation of sample for comparison (chamomile extract and yokoinin extract)]
50 mL of 1,3-butylene glycol was added to each 10 g of a mixture of flowers of the genus Camellia chamomile L., and the mixture was extracted with stirring at room temperature for 10 days, filtered, and filtrated (camomile extraction). Product). The dry solid content of the chamomile extract was 0.35%.
To 10 g of Yokuinin (JP), 100 mL of 70 vol% water-containing ethyl alcohol was added, extracted at room temperature for 3 days, and then filtered to obtain a Yokuinin extract. The dry solid content of the Yokuinin extract was 0.8%.

[例3:培養細胞によるメラニン生成抑制及び細胞生存率試験]
マウス由来のB16メラノーマ培養細胞を使用した。2枚の6穴プレートに10%FBS含有MEM培地を適量とり、B16メラノーマ細胞を播種し、37℃、二酸化炭素濃度5vol%中にて静置した。翌日、例1より得られたニトベギク抽出物を、最終固形物濃度が表1に示す濃度となるように検体調製液を添加し混和した。培養5日目に培地を交換し、再度検体調製液を添加した。翌日培地を除き、1枚のプレートについて、細胞をリン酸緩衝液(pH7)にて洗浄した後回収し、B16メラノーマ培養細胞の白色化度を以下の基準にて評価した。結果を表1に示す。
また、例2で調製したキク科に属するカミツレの抽出物と、例2で調製した既にメラニン生成抑制作用のあることが知られているヨクイニン抽出物について、同様の試験を行って評価した。結果を表1に併せて示す。
[Example 3: Suppression of melanin production and cell viability test by cultured cells]
B16 melanoma cultured cells derived from mice were used. An appropriate amount of 10% FBS-containing MEM medium was taken in two 6-well plates, seeded with B16 melanoma cells, and allowed to stand at 37 ° C. in a carbon dioxide concentration of 5 vol%. On the next day, the sample preparation solution was added to and mixed with the nitobegiku extract obtained in Example 1 so that the final solid concentration would be the concentration shown in Table 1. On day 5 of the culture, the medium was changed, and the sample preparation solution was added again. The medium was removed the next day, and the cells were collected after washing with a phosphate buffer (pH 7) on one plate, and the whitening degree of B16 melanoma cultured cells was evaluated according to the following criteria. The results are shown in Table 1.
Moreover, the same test was evaluated and evaluated about the chamomile extract which belongs to the Asteraceae prepared in Example 2, and the Yokuinin extract already prepared in Example 2 that is known to have a melanin production inhibitory effect. The results are also shown in Table 1.

(判定基準)
判定 内容
++:対照に対してきわめて白色である。
+:対照に対してあきらかに白色である。
±:対照に対してやや白色である。
−:対照と同じ黒色である。
(Criteria)
Judgment Description ++: Extremely white compared to the control.
+: Clearly white relative to the control.
±: Slightly white with respect to the control.
-: The same black color as the control.

Figure 2005255529
Figure 2005255529

表1の結果から明らかな如く、ニトベギク抽出物は、カミツレ抽出物及びヨクイニン抽出物と比較して、低濃度で高いメラニン生成抑制能を有することが認められた。このことから、ニトベギク抽出物を含有する皮膚外用剤を肌に適用することにより、優れたメラニン生成抑制作用を発揮し、日焼けによる肌の黒色化、シミ、ソバカスなどを効果的に抑制し、美白効果が期待できる。   As is clear from the results in Table 1, it was recognized that the nitrite extract has a high ability to suppress melanin production at a low concentration as compared with the chamomile extract and the yokoinin extract. Therefore, by applying an external preparation for skin containing nitobegiku extract to the skin, it exerts an excellent melanin production inhibitory effect, effectively suppresses skin blackening, spots, freckles, etc. due to sunburn, whitening The effect can be expected.

さらに、上記メラニン生成抑制能評価のために用意したプレートのうち、残りの1枚のプレートについて、細胞をホルマリン固定後、1%クリスタルバイオレット溶液を添加し染色した。各検体濃度に対する細胞生存率をモノセレーター(オリンパス社製)で測定した。ニトベギク抽出物、カミツレ抽出物及びヨクイニン抽出物それぞれについて、メラニン生成抑制能が認められた濃度における細胞生育率は、ニトベギク抽出物(10μg/L)では93%、カミツレ抽出物(100μg/L)では83%、及びヨクイニン抽出物(1000μg/L)では99%であり、ニトベギク抽出物は、メラニン生成抑制能が認められる濃度において、従来の美白剤と同等又はそれ以上の良好な安全性を示すことがわかった。   Furthermore, among the plates prepared for the evaluation of the melanin production inhibitory ability, the remaining one plate was fixed with formalin and then stained with 1% crystal violet solution. The cell viability for each sample concentration was measured with a monocerator (Olympus). The cell growth rate at a concentration at which melanin production-inhibiting ability was observed was 93% for the nitrite extract (10 μg / L), and for the chamomile extract (100 μg / L), for each of the nitrite extract, chamomile extract, and yokuinin extract. 83%, and 99% for Yokuinin extract (1000 μg / L), and Nittobegi extract should show good safety equivalent to or higher than that of conventional whitening agents at concentrations where melanin production inhibitory activity is observed. I understood.

[例4:DPPHラジカル消去能測定による抗酸化作用の評価]
安定なラジカルをもつ1、1―Diphenyl−2−picrylhydrazyl(以下DPPHと略す)の517nmにおける極大吸収が試料添加時に減少する割合により抗酸化能を評価した。
例1で得たニトベギク抽出物を、5mmol/L酢酸緩衝液で固形分濃度が0.01、0.02、0.1%となるように希釈したものを試料溶液とした。0.5mmol/LのDPPH溶液0.5mL、エタノール1mLに試料溶液1mLを加え、室温で20分反応させた後に517nmの吸光度(Abs(S))を測定した。このとき、ニトベギク抽出物の最終固形分濃度は、それぞれ、0.0004、0.002、0.004、0.02%となった。DPPH溶液0.5mL、エタノール1mLL、酢酸緩衝液1mLを対照溶液とし同様に吸光度(Abs(C))を測定した。式1によりラジカル消去率を求めた。
(式1)
ラジカル消去率=[Abs(C)―Abs(S)]/Abs(C)×100
なお、ラジカル消去率は0〜100の値で表される。ここでは、ラジカル消去率が50となる試料の固形分濃度IC50により、抗酸化能を評価した。IC50が低いほど、試料の抗酸化能が高いといえる。結果を下記表2に示した。
[Example 4: Evaluation of antioxidant effect by measuring DPPH radical scavenging ability]
Antioxidant ability was evaluated based on the rate at which the maximum absorption at 517 nm of 1,1-Diphenyl-2-picrylhydrazyl (hereinafter abbreviated as DPPH) having a stable radical was reduced when the sample was added.
A sample solution was prepared by diluting the nitrite extract obtained in Example 1 with 5 mmol / L acetic acid buffer so that the solid concentration would be 0.01, 0.02, 0.1%. After adding 1 mL of the sample solution to 0.5 mL of 0.5 mmol / L DPPH solution and 1 mL of ethanol and reacting at room temperature for 20 minutes, absorbance at 517 nm (Abs (S)) was measured. At this time, the final solid content concentrations of the nitrite extract were 0.0004, 0.002, 0.004, and 0.02%, respectively. Absorbance (Abs (C)) was measured in the same manner using DPPH solution (0.5 mL), ethanol (1 mL), and acetate buffer (1 mL) as control solutions. The radical scavenging rate was determined by Equation 1.
(Formula 1)
Radical scavenging rate = [Abs (C) −Abs (S)] / Abs (C) × 100
The radical scavenging rate is represented by a value from 0 to 100. Here, the antioxidant ability was evaluated by the solid content concentration IC50 of the sample having a radical scavenging rate of 50. It can be said that the lower the IC50, the higher the antioxidant capacity of the sample. The results are shown in Table 2 below.

また、抗酸化効果が知られているカミツレ抽出物についても同様の試験を行った。なお、評価には、例2で調製したカミツレ抽出物を用いた。結果を下記表2に併せて示す。   A similar test was also conducted on chamomile extract, which has a known antioxidant effect. For the evaluation, the chamomile extract prepared in Example 2 was used. The results are also shown in Table 2 below.

Figure 2005255529
Figure 2005255529

表2の結果から明らかなごとく、ニトベギク抽出物のIC50は、カミツレ抽出物のIC50よりも低く、高いラジカル消去能を有していることが認められた。従って、ニトベギク抽出物を抗酸化成分として肌に適用することにより、加齢、紫外線曝露等により生じる皮膚のしわ、たるみや、ツヤ、ハリの低下等を予防改善することが期待できる。   As is clear from the results in Table 2, the IC50 of the nitrite extract was lower than the IC50 of the chamomile extract and was found to have a high radical scavenging ability. Therefore, it can be expected that nitobegiku extract is applied to the skin as an antioxidant component to prevent and improve skin wrinkles, sagging, gloss, reduction of elasticity, and the like caused by aging, ultraviolet exposure, and the like.

[例5:培養細胞による細胞賦活作用の評価]
ヒト新生児由来の線維芽細胞NB1RGBを使用した。24穴プレートに培地を適量とり、線維芽細胞NB1RGBを播種し、37℃、二酸化炭素濃度5vol%中にて静置した。例1で得たニトベギク抽出物について、それぞれ最終固形分濃度が0(対照)、1μg/mLとなるように検体調製液を添加し混和した。培養4日目に培地を交換し、再度検体調製液を添加した。翌日、培地を除き、細胞をリン酸緩衝液にて洗浄した後回収し、各検体調製液で生育させた線維芽細胞NB1RGBの細胞数を対照と比較した細胞増殖率として評価した。また、細胞賦活効果があることが知られている大豆抽出物を比較品3として同様の試験を行った。なお、大豆抽出物は、大豆の種子10gに、70vol%含水エチルアルコール100mLを加えて、室温にて3日間抽出を行なった後濾過して得た。この時、大豆抽出物の乾燥固形分は0.5%であった。
[Example 5: Evaluation of cell activation by cultured cells]
Human neonatal fibroblasts NB1RGB were used. An appropriate amount of medium was taken in a 24-well plate, seeded with fibroblasts NB1RGB, and allowed to stand at 37 ° C. in a carbon dioxide concentration of 5 vol%. The sample preparation liquid was added and mixed so that the final solid content concentration was 0 (control) and 1 μg / mL, respectively, for the nitrite extract obtained in Example 1. On day 4 of the culture, the medium was changed, and the sample preparation solution was added again. On the next day, the medium was removed, the cells were washed with a phosphate buffer and then collected, and the number of fibroblasts NB1RGB grown in each specimen preparation solution was evaluated as the cell growth rate compared to the control. Moreover, the same test was done by making the soybean extract known to have a cell activation effect into the comparative product 3. The soybean extract was obtained by adding 100 mL of 70 vol% hydrous ethyl alcohol to 10 g of soybean seeds, performing extraction at room temperature for 3 days, and then filtering. At this time, the dry solid content of the soybean extract was 0.5%.

(評価基準)
細胞数は、血球計算盤を用いてカウントした。各検体調製液を添加して生育させた細胞数を対照の細胞数と比較し、その細胞増殖率を指標として細胞賦活効果を評価した。これらの結果を表3に示した。
(Evaluation criteria)
The number of cells was counted using a hemocytometer. The number of cells grown by adding each sample preparation solution was compared with the number of control cells, and the cell activation effect was evaluated using the cell proliferation rate as an index. These results are shown in Table 3.

(結果)

Figure 2005255529
(result)
Figure 2005255529

表3の結果から明らかなごとく、ニトベギク抽出物は、ヒト新生児由来の線維芽細胞NB1RGBに対して、大豆抽出物と同等の高い細胞賦活能を有していることが認められた。従って、ニトベギク抽出物を細胞賦活成分として肌に適用することにより、加齢、紫外線曝露等により生じる皮膚のしわ、たるみや、ツヤ、ハリの低下等を予防改善することが期待できる。   As is clear from the results in Table 3, it was confirmed that the extract of nitobegiku has a high cell activation ability equivalent to that of the soybean extract with respect to human neonatal fibroblast NB1RGB. Therefore, it can be expected that nitobegiku extract is applied to the skin as a cell activation component to prevent and improve skin wrinkles, sagging, gloss, reduction of elasticity, and the like caused by aging, ultraviolet exposure, and the like.

[例6:化粧水]
下記成分(3)〜(5)及び(9)〜(11)を混合溶解した溶液と、成分(1)、(2)、(6)〜(8)及び(12)を混合溶解した溶液とを混合して、均一にし、化粧水を得た。
(処方) (%)
(1)グリセリン 5.0
(2)1,3−ブチレングリコール 6.5
(3)ポリオキシエチレン(20E.O.)ソルビタン 1.2
モノラウリン酸エステル
(4)エチルアルコール 8.0
(5)ニトベギク抽出物*1 0.005
(6)L−アスコルビン酸リン酸エステルマグネシウム*2 0.5
(7)乳酸 0.05
(8)乳酸ナトリウム 0.1
(9)パラメトキシケイ皮酸−2−エチルヘキシル 3.0
(10)防腐剤 適量
(11)香料 適量
(12)精製水 残量
*1 例1で製造したもの
*2 シグマ社製
[Example 6: lotion]
A solution in which the following components (3) to (5) and (9) to (11) are mixed and dissolved; and a solution in which the components (1), (2), (6) to (8) and (12) are mixed and dissolved; Were mixed to obtain a skin lotion.
(Prescription) (%)
(1) Glycerin 5.0
(2) 1,3-butylene glycol 6.5
(3) Polyoxyethylene (20E.O.) sorbitan 1.2
Monolaurate (4) Ethyl alcohol 8.0
(5) Nitobegi extract * 1 0.005
(6) Magnesium L-ascorbate phosphate * 2 0.5
(7) Lactic acid 0.05
(8) Sodium lactate 0.1
(9) Paramethoxycinnamic acid-2-ethylhexyl 3.0
(10) Preservative Appropriate amount (11) Fragrance Appropriate amount (12) Purified water Remaining amount * 1 Made in Example 1 * 2 Sigma

[例7:乳液]
下記成分(1)〜(6)及び(10)、(13)を加熱混合し、70℃に保った混合物1を調製した。成分(12)及び(14)の一部を加熱混合し、70℃に保った混合物2を調製した。成分(14)の残部で成分(7)〜(9)を溶解させた混合物3を調製した。混合物1に混合物2を加え混合し、均一に乳化した。さらにこの乳化物を冷却後、混合物3を加え、均一に混合した。この混合物に(11)を加え、十分に攪拌し、さらに(15)を加え均一に混合して乳液を得た。
(処方) (%)
(1)ポリオキシエチレン(10E.O.)ソルビタン 1.0
モノステアレート
(2)ポリオキシエチレン(60E.O.)ソルビット 0.5
テトラオレエート
(3)グリセリルモノステアレート 1.0
(4)ステアリン酸 0.5
(5)ベヘニルアルコール 0.5
(6)スクワラン 8.0
(7)グリチルリチン酸ジカリウム*1 0.3
(8)ニトベギク抽出物*2 0.02
(9)カンゾウ抽出物*3 0.1
(10)防腐剤 0.1
(11)カルボキシビニルポリマー 0.1
(12)水酸化ナトリウム 0.05
(13)エチルアルコール 5.0
(14)精製水 残量
(15)香料 適量
*1 シグマ社製
*2 例1で製造したもの
*3 丸善製薬社製
[Example 7: Latex]
The following components (1) to (6) and (10) and (13) were heated and mixed to prepare a mixture 1 maintained at 70 ° C. A part of components (12) and (14) was heated and mixed to prepare a mixture 2 kept at 70 ° C. A mixture 3 was prepared by dissolving the components (7) to (9) with the remainder of the component (14). The mixture 2 was added to the mixture 1 and mixed, and the mixture was uniformly emulsified. Furthermore, after cooling this emulsion, the mixture 3 was added and mixed uniformly. (11) was added to this mixture, and it fully stirred, and also (15) was added and mixed uniformly to obtain an emulsion.
(Prescription) (%)
(1) Polyoxyethylene (10E.O.) sorbitan 1.0
Monostearate (2) Polyoxyethylene (60EO) Sorbit 0.5
Tetraoleate (3) Glyceryl monostearate 1.0
(4) Stearic acid 0.5
(5) Behenyl alcohol 0.5
(6) Squalane 8.0
(7) Dipotassium glycyrrhizinate * 1 0.3
(8) Nitobegi extract * 2 0.02
(9) Daylily extract * 3 0.1
(10) Preservative 0.1
(11) Carboxyvinyl polymer 0.1
(12) Sodium hydroxide 0.05
(13) Ethyl alcohol 5.0
(14) Purified water Remaining amount (15) Fragrance Appropriate amount * 1 Made by Sigma * 2 Made in Example 1 * 3 Maruzen Pharmaceutical Co., Ltd.

例6で調製した化粧水及び例7で調製した乳液は、いずれも肌に適用することによって、肌を美白にし、且つ肌にはりやつやを与える、優れた化粧料であった。また、これらの化粧水及び乳液の安定性も良好であった。   Both the lotion prepared in Example 6 and the emulsion prepared in Example 7 were excellent cosmetics that, when applied to the skin, whitened the skin and gave the skin a gloss and gloss. Moreover, the stability of these lotions and emulsions was also good.

本発明の皮膚外用剤は、化粧料、医薬部外品及び外用医薬品等、種々の用途に供することができる。中でも、美白効果及び/又は老化防止効果に優れているので、化粧料として特に有用である。   The external preparation for skin of the present invention can be used for various applications such as cosmetics, quasi drugs, and external medicines. Especially, since it is excellent in the whitening effect and / or the anti-aging effect, it is particularly useful as a cosmetic.

Claims (3)

ニトベギク抽出物を有効成分として含有する皮膚外用剤。 An external preparation for skin containing nitobegiku extract as an active ingredient. 前記ニトベギク抽出物を美白剤として含有する請求項1に記載の皮膚外用剤。 The skin external preparation of Claim 1 which contains the said nitobegiku extract as a whitening agent. 前記ニトベギク抽出物を老化防止剤として含有する請求項1に記載の皮膚外用剤。 The skin external preparation of Claim 1 which contains the said nitobegiku extract as an anti-aging agent.
JP2004065084A 2004-03-09 2004-03-09 Topical skin preparation Expired - Fee Related JP4541728B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004065084A JP4541728B2 (en) 2004-03-09 2004-03-09 Topical skin preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004065084A JP4541728B2 (en) 2004-03-09 2004-03-09 Topical skin preparation

Publications (2)

Publication Number Publication Date
JP2005255529A true JP2005255529A (en) 2005-09-22
JP4541728B2 JP4541728B2 (en) 2010-09-08

Family

ID=35081621

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004065084A Expired - Fee Related JP4541728B2 (en) 2004-03-09 2004-03-09 Topical skin preparation

Country Status (1)

Country Link
JP (1) JP4541728B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013541960A (en) * 2010-10-29 2013-11-21 株式會社アモーレパシフィック Kit for searching for skin active substance containing Klotho gene and method for searching for skin active substance using the same

Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02264722A (en) * 1989-04-04 1990-10-29 Tsumura & Co Anticancer agent
JPH03221587A (en) * 1990-01-29 1991-09-30 Dainippon Ink & Chem Inc Water-soluble antioxidant
JPH05271045A (en) * 1992-03-30 1993-10-19 Kose Corp Cosmetic
JPH07242559A (en) * 1990-08-30 1995-09-19 Masakiyo Takahashi Diabetes-treating medicine
JPH08127538A (en) * 1994-10-31 1996-05-21 Masakiyo Takahashi Antidiabetic agent
JPH08175964A (en) * 1994-12-26 1996-07-09 Nonogawa Shoji Kk Skin preparation for external use
JPH08268890A (en) * 1995-03-31 1996-10-15 Eisai Co Ltd Prophylactic and remedy for hepatitis c
JPH09143465A (en) * 1995-11-21 1997-06-03 Dainippon Ink & Chem Inc Antioxidative composition
JP2000319159A (en) * 1999-05-10 2000-11-21 Nonogawa Shoji Kk Skin preparation for external use
JP2001506589A (en) * 1996-11-01 2001-05-22 サム チョン ダング パーム.コ.、エルティディ. Pharmaceutical composition for treating diabetes
JP2002179581A (en) * 2000-12-15 2002-06-26 Yakult Honsha Co Ltd Skin aging inhibitor
JP2002226389A (en) * 2001-01-22 2002-08-14 Sun Yon Lee Composition for treatment of diabetes
JP2002370962A (en) * 2001-06-13 2002-12-24 Maruzen Pharmaceut Co Ltd Bleaching preparation and cosmetic for preventing and improving aging of skin
JP2004137166A (en) * 2002-10-16 2004-05-13 Noevir Co Ltd Skin care preparation for external use, cell activator and antioxidant
JP2005179339A (en) * 2003-11-27 2005-07-07 Hiro International Co Ltd New compound and medicinal composition

Patent Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02264722A (en) * 1989-04-04 1990-10-29 Tsumura & Co Anticancer agent
JPH03221587A (en) * 1990-01-29 1991-09-30 Dainippon Ink & Chem Inc Water-soluble antioxidant
JPH07242559A (en) * 1990-08-30 1995-09-19 Masakiyo Takahashi Diabetes-treating medicine
JPH05271045A (en) * 1992-03-30 1993-10-19 Kose Corp Cosmetic
JPH08127538A (en) * 1994-10-31 1996-05-21 Masakiyo Takahashi Antidiabetic agent
JPH08175964A (en) * 1994-12-26 1996-07-09 Nonogawa Shoji Kk Skin preparation for external use
JPH08268890A (en) * 1995-03-31 1996-10-15 Eisai Co Ltd Prophylactic and remedy for hepatitis c
JPH09143465A (en) * 1995-11-21 1997-06-03 Dainippon Ink & Chem Inc Antioxidative composition
JP2001506589A (en) * 1996-11-01 2001-05-22 サム チョン ダング パーム.コ.、エルティディ. Pharmaceutical composition for treating diabetes
JP2000319159A (en) * 1999-05-10 2000-11-21 Nonogawa Shoji Kk Skin preparation for external use
JP2002179581A (en) * 2000-12-15 2002-06-26 Yakult Honsha Co Ltd Skin aging inhibitor
JP2002226389A (en) * 2001-01-22 2002-08-14 Sun Yon Lee Composition for treatment of diabetes
JP2002370962A (en) * 2001-06-13 2002-12-24 Maruzen Pharmaceut Co Ltd Bleaching preparation and cosmetic for preventing and improving aging of skin
JP2004137166A (en) * 2002-10-16 2004-05-13 Noevir Co Ltd Skin care preparation for external use, cell activator and antioxidant
JP2005179339A (en) * 2003-11-27 2005-07-07 Hiro International Co Ltd New compound and medicinal composition

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JPN6009033060, Menut, Chantal, "Aromatic plants of tropical Central Africa. IX. Chemical composition of flower essential oils of T", Journal of Essential Oil Research, 1992, 4(6), 651−653 *
JPN6009033062, Menut, Chantal, "Aromatic plants of tropical Central Africa. IX. Chemical composition of flower essential oils of T", Journal of Essential Oil Research, 1991, 3, 399−402 *
JPN6009033064, "キク科植物Tithonia diversifolia(ニトベギク)のセスキテルペノイド成分について", 日本薬学会年会要旨集, 20040305, Vol.124th No.2, Page.139, JP *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013541960A (en) * 2010-10-29 2013-11-21 株式會社アモーレパシフィック Kit for searching for skin active substance containing Klotho gene and method for searching for skin active substance using the same

Also Published As

Publication number Publication date
JP4541728B2 (en) 2010-09-08

Similar Documents

Publication Publication Date Title
JP2007210915A (en) Skin preparation for external use
JP3987793B2 (en) Topical skin preparation
JP5770428B2 (en) Singlet oxygen scavenger, skin external preparation and cosmetic using the singlet oxygen scavenger
JP2009149562A (en) External preparation for skin
JP4167247B2 (en) Skin preparation
JP5226200B2 (en) Sulfated glycosaminoglycan production promoter and skin external preparation containing the same
JP5770426B2 (en) Singlet oxygen scavenger, skin external preparation and cosmetic using the singlet oxygen scavenger
JP3754646B2 (en) Topical skin preparation
JP2011195539A (en) Elastase activity inhibitor
JP2010150173A (en) Skin whitening agent, melanogenesis inhibitor, and skin whitening skin external preparation
JP2000344653A (en) Eraser for active oxygen and skin cosmetic
JP4541728B2 (en) Topical skin preparation
JP2005263655A (en) Antioxidant
JP2007238597A (en) Skin care preparation
JP4653513B2 (en) Skin preparation
JP2012201615A (en) Elastase activity inhibitor
JP2009256326A (en) Skin whitening preparation, and skincare preparation
JP3746260B2 (en) Topical skin preparation
JP2009249366A (en) Collagen production promotor and anti-aging skin preparation for external use
JP2004107269A (en) Carbonylation inhibiting agent for protein, skin care preparation for external use, and method
JP2009234976A (en) Cell activator and external preparation for skin for antiaging
JP2006206537A (en) External preparation for skin and method for bleaching skin
JP4638166B2 (en) Genticic acid derivative and topical skin preparation using the same
JP2007320851A (en) Skin care preparation for external use
JP2009249365A (en) Cell activator and anti-aging skin preparation for external use

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051209

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061002

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20080331

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090707

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090818

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091110

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100106

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100608

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100624

R150 Certificate of patent or registration of utility model

Ref document number: 4541728

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130702

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees